2. Academic Validation
  3. Development of a next-generation endogenous OCT4 inducer and its anti-aging effect in vivo

Development of a next-generation endogenous OCT4 inducer and its anti-aging effect in vivo

  • Eur J Med Chem. 2023 Sep 5;257:115513. doi: 10.1016/j.ejmech.2023.115513.
Han Kang 1,  Sebastian Hasselbeck 2,  Katerina Taškova 3,  Nessa Wang 1,  Luuk N van Oosten 1,  Ralf Mrowka 4,  Jochen Utikal 5,  Miguel A Andrade-Navarro 3,  Jichang Wang 6,  Stefan Wölfl 1,  Xinlai Cheng 7
Affiliations

Affiliations

  • 1 Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Germany.
  • 2 Buchmann Institute for Molecular Life Sciences, Goethe University Frankfurt am Main, Germany.
  • 3 Faculty of Biology, Johannes Gutenberg University Mainz, Germany.
  • 4 Experimentelle Nephrologie, KIM III, Universitätsklinikum, Jena, Germany.
  • 5 Skin Cancer Unit (G300), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • 6 Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
  • 7 Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Germany; Buchmann Institute for Molecular Life Sciences, Goethe University Frankfurt am Main, Germany; Frankfurt Cancer Institute, Germany. Electronic address: [email protected].
PMID: 37253308 DOI: 10.1016/j.ejmech.2023.115513
Abstract

The identification of small molecules capable of replacing transcription factors has been a longstanding challenge in the generation of human chemically induced pluripotent stem cells (iPSCs). Recent studies have shown that ectopic expression of OCT4, one of the master pluripotency regulators, compromised the developmental potential of resulting iPSCs, This highlights the importance of finding endogenous OCT4 inducers for the generation of clinical-grade human iPSCs. Through a cell-based high throughput screen, we have discovered several new OCT4-inducing compounds (O4Is). In this work, we prepared metabolically stable analogues, including O4I4, which activate endogenous OCT4 and associated signaling pathways in various cell lines. By combining these with a transcription factor cocktail consisting of SOX2, KLF4, MYC, and LIN28 (referred to as "CSKML") we achieved to reprogram human fibroblasts into a stable and authentic pluripotent state without the need for exogenous OCT4. In Caenorhabditis elegans and Drosophila, O4I4 extends lifespan, suggesting the potential application of OCT4-inducing compounds in regenerative medicine and rejuvenation therapy.

Keywords

Anti-aging; Cell therapy; Chemially induced pluripotent stem cells; OCT4-Inducing compounds; RNA Splicing; Regeneration.

Figures
Products